The New Brunswick, N.J., maker of baby products, biotech drugs and medical devices reported net income of $3.93 billion, or $1.44 per share, up 4.5 ...
News
- Prescription drugs, lower taxes, power J&J 3Q beat
- SABJ Business Minute: What you need to know to start your week
BioAffinity Technologies, a San Antonio-based biotech, has struck a deal with another local company, Precision Pathology Services, to sell its early ...
- Marty Wender's Story Inspires Support for New Burn Care Therapies
Almost three years ago, San Antonio real estate developer Marty Wender learned firsthand about the benefits of the robust healthcare and biosciences ...
- Study: DNA websites cast broad net for identifying people
Amy McGuire, a professor of biomedical ethics at the Baylor College of Medicine in Houston, said that police searches using DNA and genealogy ...
- Recon: BMS, Compugen to Test Investigational Antibody and Opdivo in Advanced Solid Tumors
US crackdown on foreign investments could cool Asia's desire for US biotech (STAT); As China Hunts For New Cures, Investors Flood US Biotech ...